OSAKA - Japanese pharmaceutical firm Shionogi & Co. plans to seek state approval for its oral coronavirus drug by the end of this year, in the hope of offering at-home treatment and easing strains on hospitals, company sources said Friday.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
